10274924 · Active · incorporated 10 years, 2 months ago · London
Biotech Drug Discovery Healthcare Series B+
A clinical-stage biopharmaceutical company focused on developing targeted therapeutics for Fragile X Syndrome.
Kaerus Bioscience is a private limited company registered at Companies House under number 10274924, incorporated on 12 July 2016, with a registered office in London. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 94 filings for this company, including 3 funding rounds. Its most recent round closed in October 2024, raising €6.5m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 3 | Oct 2024 | €6.5m | €0.57 |
| Round 2 | Dec 2023 | €7.2m | €0.224 |
| Round 1 | Aug 2022 | €434k | — |
Showing the 10 most recent of 94 filings.
See the complete cap table with every shareholder, founder tags, dilution across 32 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.